<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Surg</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Annals of surgery</journal-title></journal-title-group><issn pub-type="ppub">0003-4932</issn><issn pub-type="epub">1528-1140</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10205913</article-id><article-id pub-id-type="pmcid-ver">PMC10205913.319</article-id><article-id pub-id-type="pmcaid">10205913</article-id><article-id pub-id-type="pmcaiid">10205913</article-id><article-id pub-id-type="manuscript-id">NIHMS1851529</article-id><article-id pub-id-type="pmid">36538617</article-id><article-id pub-id-type="doi">10.1097/SLA.0000000000005767</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1851529</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1851529</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Prevalence of Unhealthy Substance Use and Associated Characteristics Among Patients Presenting for Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Fernandez</surname><given-names initials="AC">Anne C</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Waljee</surname><given-names initials="JF">Jennifer F</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gunaseelan</surname><given-names initials="V">Vidhya</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brummett</surname><given-names initials="CM">Chad M</given-names></name><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Englesbe</surname><given-names initials="MJ">Michael J</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bicket</surname><given-names initials="MC">Mark C</given-names></name><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA</aff><aff id="A2"><label>2</label>Department of Surgery, University of Michigan, Ann Arbor, MI, USA</aff><aff id="A3"><label>3</label>Opioid Prescribing Engagement Network, Institute for Healthcare Policy and Innovation, University of Michigan School of Public Health, University of Michigan, Ann Arbor, MI, USA</aff><aff id="A4"><label>4</label>Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA</aff><author-notes><corresp id="CR1"><bold>Corresponding Author/Reprint Requests:</bold> Mark Bicket, MD, PhD, University of Michigan School of Medicine, Department of Anesthesiology, 1500 E Medical Center Drive, Ann Arbor, MI 48109 (<email>mbicket@med.umich.edu</email>, 734-936-4280).</corresp><fn fn-type="COI-statement" id="FN1"><p id="P27"><bold>Disclosures:</bold> Dr. Bicket reports past personal fees and other from Axial Healthcare and past personal fees from Alosa Health outside the submitted work. Dr. Brummett serves as a consultant for <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.herontx.com/" ext-link-type="uri">Heron Therapeutics</ext-link>, a biotech company that produces a non-opioid analgesic for acute pain, and he served as a one-time consultant for <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.vrtx.com/" ext-link-type="uri">Vertex Pharmaceuticals</ext-link>, Alosa Health, and the Benter Foundation. In addition, Dr. Brummett provides expert medicolegal testimony unrelated to this viewpoint. The other authors report no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2022</year></pub-date><volume>278</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">436422</issue-id><fpage>e740</fpage><lpage>e744</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>12</month><year>2022</year></date></event><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-01 00:25:29.690"><day>01</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1851529.pdf"/><abstract id="ABS1"><title>Structured Abstract</title><sec id="S1"><title>Objective:</title><p id="P1">To assess the prevalence of and identify characteristics associated with unhealthy use before surgery.</p></sec><sec id="S2"><title>Summary Background Data:</title><p id="P2">Although the escalation in US drug overdose deaths is apparent, the unhealthy use of substances among patients presenting for surgery is unclear.</p></sec><sec id="S3"><title>Methods:</title><p id="P3">We conducted retrospective study of patients presenting for elective surgical procedures between December 2018 and July 2021 and prospectively recruited to one of two clinical research studies (Michigan Genomics Initiative, oPIOIDS Study). The primary outcome was unhealthy substance use in the past 12 months as determined using the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS-1) tool.</p></sec><sec id="S4"><title>Results:</title><p id="P4">Among 1,912 patients, unhealthy substance use was reported in 768 (40.2%). The most common substances with unhealthy use were illicit drugs (385 [20.1%]), followed by alcohol (358 [18.7%]), tobacco (262 [13.7%]), and prescription medications (86 [4.5%]). Patients reporting unhealthy substance use were significantly more likely to be younger, male (aOR 1.95 [95% CI, 1.58&#8211;2.42]), and have higher scores for pain (aOR 1.07 [95% CI 1.02&#8211;1.13]) and anxiety (aOR 1.03 [95% CI 1.01&#8211;1.04]). Unhealthy substance use was more common among surgical procedures of the forearm, wrist, and hand (aOR 2.58 [95% CI, 1.01&#8211;6.55]).</p></sec><sec id="S5"><title>Conclusions:</title><p id="P5">As many as 2 in 5 patients in the preoperative period may present with unhealthy substance use before elective surgery. Given the potential impact of substance use on surgical outcomes, increased recognition of the problem by screening patients is a critical next step for surgeons and perioperative care teams.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Mini-Abstract</title><p id="P6">In this retrospective study of 1,912 patients presenting for surgery at a large Midwestern academic medical center, 40.2% (768) patients reported preoperative unhealthy substance use, including illicit drugs (20.1%), alcohol (18.7%) and tobacco (13.7%). Surgeries of the pelvis (adjusted odds ratio 5.0) and forearm, wrist, and hand (aOR 2.6) had the highest prevalence of preoperative unhealthy substance use.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>